Kurs
-1,52%
Likviditet
0,95 MSEK
Prenumeration
Kalender
Est. tid* | ||
2026-02-12 | 07:30 | Bokslutskommuniké 2025 |
2025-10-22 | 07:30 | Kvartalsrapport 2025-Q3 |
2025-07-23 | 07:30 | Kvartalsrapport 2025-Q2 |
2025-04-25 | N/A | X-dag ordinarie utdelning SECARE 0.25 SEK |
2025-04-24 | N/A | Årsstämma |
2025-04-24 | 07:30 | Kvartalsrapport 2025-Q1 |
2025-02-13 | - | Bokslutskommuniké 2024 |
2024-10-23 | - | Kvartalsrapport 2024-Q3 |
2024-07-25 | - | Kvartalsrapport 2024-Q2 |
2024-04-26 | - | X-dag ordinarie utdelning SECARE 0.23 SEK |
2024-04-25 | - | Årsstämma |
2024-04-25 | - | Kvartalsrapport 2024-Q1 |
2024-02-15 | - | Bokslutskommuniké 2023 |
2023-10-25 | - | Kvartalsrapport 2023-Q3 |
2023-07-27 | - | Kvartalsrapport 2023-Q2 |
2023-05-02 | - | X-dag ordinarie utdelning SECARE 0.22 SEK |
2023-04-28 | - | Årsstämma |
2023-04-28 | - | Kvartalsrapport 2023-Q1 |
2023-02-16 | - | Bokslutskommuniké 2022 |
2022-10-27 | - | Kvartalsrapport 2022-Q3 |
2022-10-19 | - | Extra Bolagsstämma 2022 |
2022-07-28 | - | Kvartalsrapport 2022-Q2 |
2022-05-12 | - | Kvartalsrapport 2022-Q1 |
2022-04-29 | - | X-dag ordinarie utdelning SECARE 0.20 SEK |
2022-04-28 | - | Årsstämma |
2022-02-17 | - | Bokslutskommuniké 2021 |
2021-10-28 | - | Kvartalsrapport 2021-Q3 |
2021-07-29 | - | Kvartalsrapport 2021-Q2 |
2021-05-24 | - | Split SECARE 1:5 |
2021-04-30 | - | X-dag ordinarie utdelning SECARE 0.80 SEK |
2021-04-29 | - | Årsstämma |
2021-04-29 | - | Kvartalsrapport 2021-Q1 |
2021-02-18 | - | Bokslutskommuniké 2020 |
2020-10-22 | - | Kvartalsrapport 2020-Q3 |
2020-09-11 | - | Extra Bolagsstämma 2020 |
2020-07-24 | - | Kvartalsrapport 2020-Q2 |
2020-04-22 | - | X-dag ordinarie utdelning SECARE 0.70 SEK |
2020-04-21 | - | Årsstämma |
2020-04-21 | - | Kvartalsrapport 2020-Q1 |
2020-02-13 | - | Bokslutskommuniké 2019 |
2019-10-24 | - | Kvartalsrapport 2019-Q3 |
2019-07-26 | - | Kvartalsrapport 2019-Q2 |
2019-04-26 | - | X-dag ordinarie utdelning SECARE 0.00 SEK |
2019-04-25 | - | Årsstämma |
2019-04-25 | - | Kvartalsrapport 2019-Q1 |
2019-02-14 | - | Bokslutskommuniké 2018 |
2018-10-25 | - | Kvartalsrapport 2018-Q3 |
2018-07-27 | - | Kvartalsrapport 2018-Q2 |
2018-04-26 | - | Kvartalsrapport 2018-Q1 |
2018-04-25 | - | X-dag ordinarie utdelning SECARE 0.00 SEK |
2018-04-24 | - | Årsstämma |
2018-02-22 | - | Bokslutskommuniké 2017 |
2017-10-26 | - | Kvartalsrapport 2017-Q3 |
2017-08-25 | - | Kvartalsrapport 2017-Q2 |
2017-04-28 | - | X-dag ordinarie utdelning SECARE 0.00 SEK |
2017-04-27 | - | Årsstämma |
2017-04-27 | - | Kvartalsrapport 2017-Q1 |
2017-02-16 | - | Bokslutskommuniké 2016 |
2016-10-27 | - | Kvartalsrapport 2016-Q3 |
2016-08-25 | - | Kvartalsrapport 2016-Q2 |
Beskrivning
Land | Sverige |
---|---|
Lista | First North Stockholm |
Sektor | Hälsovård |
Industri | Läkemedel & Handel |
The 24th of April at 7:30am CEST Swedencare AB (publ) will publish the interim report of Q1 2025. A presentation of the report will be held the same day at 10:30am CEST via live webinar. The presentation will be available on the website at 9:30am CEST.
Swedencare invites shareholders and analysts to a presentation of the Q1 report where CEO Håkan Lagerberg and CFO Jenny Graflind will comment on the report. The presentation will be held at 10:30-11:30am CEST and can be followed via live webinar. Geoff Granger, CEO of the subsidiary NaturVet will also take part in the presentation. The report will be published at 7:30am CEST and will be available at www.swedencare.com.
The presentation will be held in English and after the presentation questions can be asked live via the webinar. No registration is needed.
Please use this link to join the webinar: https://us05web.zoom.us/j/82213052413
After the presentation a recorded version will be available on our webpage.
For more information, please contact:
Håkan Lagerberg, CEO Swedencare
Phone: +46 (0)73 517 01 70
Email: hakan.lagerberg@swedencare.se
Jenny Graflind, CFO Swedencare
Phone: +46 (0)73 944 85 54
Email: jenny.graflind@swedencare.se
FNCA is the Certified Adviser of the Company
Please visit the Company homepage www.swedencare.com
About Swedencare
Swedencare is listed on the NASDAQ First North Growth Market and also trades on the OTCQX® Best Market. We develop, produce, and sell premium products in the global and rapidly growing pet healthcare market, focusing on cats, dogs, and horses. Our extensive product portfolio includes strong brands such as NaturVet®, Innovet, Pet MD®, Rx Vitamins®, nutravet®, Rileys®, and ProDen PlaqueOff®, the original solution for good oral health.
With headquarters in Malmö, our products are sold in approximately 70 countries through veterinarians, pet stores, and online. Our extensive distribution network consists of subsidiaries in nine countries, along with an international network of retailers. Swedencare has experienced strong growth for several years while maintaining high profitability.